BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 10706114)

  • 1. Microtubule disruption induced in vivo by alkylation of beta-tubulin by 1-aryl-3-(2-chloroethyl)ureas, a novel class of soft alkylating agents.
    Legault J; Gaulin JF; Mounetou E; Bolduc S; Lacroix J; Poyet P; Gaudreault RC
    Cancer Res; 2000 Feb; 60(4):985-92. PubMed ID: 10706114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic and antitumoral activity of phenyl-3-(2-chloroethyl)ureas: a class of soft alkylating agents disrupting microtubules that are unaffected by cell adhesion-mediated drug resistance.
    Petitclerc E; Deschesnes RG; Côté MF; Marquis C; Janvier R; Lacroix J; Miot-Noirault E; Legault J; Mounetou E; Madelmont JC; C -Gaudreault R
    Cancer Res; 2004 Jul; 64(13):4654-63. PubMed ID: 15231678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alkylation of beta-tubulin on Glu 198 by a microtubule disrupter.
    Bouchon B; Chambon C; Mounetou E; Papon J; Miot-Noirault E; Gaudreault RC; Madelmont JC; Degoul F
    Mol Pharmacol; 2005 Nov; 68(5):1415-22. PubMed ID: 16099845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alkylation potency and protein specificity of aromatic urea derivatives and bioisosteres as potential irreversible antagonists of the colchicine-binding site.
    Fortin JS; Lacroix J; Desjardins M; Patenaude A; Petitclerc E; C-Gaudreault R
    Bioorg Med Chem; 2007 Jul; 15(13):4456-69. PubMed ID: 17498960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the covalent binding of N-phenyl-N'-(2-chloroethyl)ureas to {beta}-tubulin: importance of Glu198 in microtubule stability.
    Fortin S; Bouchon B; Chambon C; Lacroix J; Moreau E; Chezal JM; Degoul F; C-Gaudreault R
    J Pharmacol Exp Ther; 2011 Feb; 336(2):460-7. PubMed ID: 20978170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of an aryl chloroethyl urea on tubulin and vimentin syntheses in a human breast cancer cell line.
    Poyet P; Ritchot N; Béchard P; Gaudreáult RC
    Anticancer Res; 1993; 13(5A):1447-52. PubMed ID: 8239518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition and metabolism of a novel antineoplastic agent, 4-tert-butyl-[3-(2-chloroethyl)ureido]benzene, in mice.
    Maurizis JC; Rapp M; Azim EM; Gaudreault RC; Veyre A; Madelmont JC
    Drug Metab Dispos; 1998 Feb; 26(2):146-51. PubMed ID: 9456301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective alkylation of beta(II)-tubulin and thioredoxin-1 by structurally related subsets of aryl chloroethylureas leading to either anti-microtubules or redox modulating agents.
    Fortin JS; Côté MF; Lacroix J; Desjardins M; Petitclerc E; C-Gaudreault R
    Bioorg Med Chem; 2008 Aug; 16(15):7277-90. PubMed ID: 18617414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of N-phenyl-N'-(2-chloroethyl)ureas in the colchicine-binding site at the interface between alpha- and beta-tubulin.
    Fortin S; Wei L; Moreau E; Labrie P; Petitclerc E; Kotra LP; C-Gaudreault R
    Bioorg Med Chem; 2009 May; 17(10):3690-7. PubMed ID: 19398206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alkylation of prohibitin by cyclohexylphenyl-chloroethyl urea on an aspartyl residue is associated with cell cycle G(1) arrest in B16 cells.
    Bouchon B; Papon J; Communal Y; Madelmont JC; Degoul F
    Br J Pharmacol; 2007 Oct; 152(4):449-55. PubMed ID: 17704829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New soft alkylating agents with enhanced cytotoxicity against cancer cells resistant to chemotherapeutics and hypoxia.
    Patenaude A; Deschesnes RG; Rousseau JL; Petitclerc E; Lacroix J; Côté MF; C-Gaudreault R
    Cancer Res; 2007 Mar; 67(5):2306-16. PubMed ID: 17332362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Phenyl-N'-(2-chloroethyl)ureas (CEU) as potential antineoplastic agents. Part 2: role of omega-hydroxyl group in the covalent binding to beta-tubulin.
    Fortin S; Moreau E; Patenaude A; Desjardins M; Lacroix J; Rousseau JL; C-Gaudreault R
    Bioorg Med Chem; 2007 Feb; 15(3):1430-8. PubMed ID: 17118664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Phenyl-N'-(2-chloroethyl)ureas (CEUs) as potential antineoplastic agents. Part 3: role of carbonyl groups in the covalent binding to the colchicine-binding site.
    Moreau E; Fortin S; Lacroix J; Patenaude A; Rousseau JL; C-Gaudreault R
    Bioorg Med Chem; 2008 Feb; 16(3):1206-17. PubMed ID: 17998163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
    Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC
    Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of cys124 and ser239 in the functional properties of human betaIII tubulin.
    Joe PA; Banerjee A; Ludueña RF
    Cell Motil Cytoskeleton; 2008 Jun; 65(6):476-86. PubMed ID: 18435451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estramustine depolymerizes microtubules by binding to tubulin.
    Dahllöf B; Billström A; Cabral F; Hartley-Asp B
    Cancer Res; 1993 Oct; 53(19):4573-81. PubMed ID: 8402630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenesis of beta-tubulin cysteine residues in Saccharomyces cerevisiae: mutation of cysteine 354 results in cold-stable microtubules.
    Gupta ML; Bode CJ; Dougherty CA; Marquez RT; Himes RH
    Cell Motil Cytoskeleton; 2001 Jun; 49(2):67-77. PubMed ID: 11443737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of class III beta-tubulin reduces microtubule assembly and confers resistance to paclitaxel.
    Hari M; Yang H; Zeng C; Canizales M; Cabral F
    Cell Motil Cytoskeleton; 2003 Sep; 56(1):45-56. PubMed ID: 12905530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloroethyl urea derivatives block tumour growth and thioredoxin-1 nuclear translocation.
    Patenaude A; Fortin JS; Deschenes R; Côté MF; Lacroix J; C-Gaudreault R; Petitclerc E
    Can J Physiol Pharmacol; 2010 Nov; 88(11):1102-14. PubMed ID: 21076498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of endogenous beta-tubulin isotype expression as a result of human beta(III)cDNA transfection into prostate carcinoma cells.
    Ranganathan S; McCauley RA; Dexter DW; Hudes GR
    Br J Cancer; 2001 Sep; 85(5):735-40. PubMed ID: 11531260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.